Aspen Aerogels (NYSE:ASPN) Earns Buy Rating from Roth Mkm

Roth Mkm reiterated their buy rating on shares of Aspen Aerogels (NYSE:ASPN) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $36.00 price target on the construction company’s stock, up from their previous price target of $28.00.

ASPN has been the subject of a number of other research reports. TheStreet raised shares of Aspen Aerogels from a d+ rating to a c- rating in a research note on Wednesday, March 6th. Canaccord Genuity Group increased their target price on shares of Aspen Aerogels from $18.00 to $28.00 and gave the stock a buy rating in a research report on Friday, May 3rd. Piper Sandler increased their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock an overweight rating in a research report on Wednesday, May 29th. TD Cowen increased their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock a buy rating in a research report on Wednesday, June 5th. Finally, HC Wainwright increased their target price on shares of Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a research report on Friday, May 3rd. One analyst has rated the stock with a sell rating and eight have given a buy rating to the company. According to MarketBeat.com, Aspen Aerogels presently has a consensus rating of Moderate Buy and a consensus price target of $30.75.

Aspen Aerogels Trading Down 1.9 %

NYSE ASPN opened at $30.10 on Wednesday. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $31.74. The company has a 50-day moving average of $23.77 and a 200-day moving average of $17.80. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The company has a market cap of $2.29 billion, a P/E ratio of -68.41 and a beta of 2.29.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, May 1st. The construction company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.14. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $94.50 million during the quarter, compared to the consensus estimate of $73.04 million. As a group, equities analysts predict that Aspen Aerogels will post 0.08 earnings per share for the current year.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young sold 256,944 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the transaction, the chief executive officer now owns 502,855 shares in the company, valued at approximately $14,703,480.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Donald R. Young sold 256,944 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total transaction of $7,513,042.56. Following the completion of the transaction, the chief executive officer now directly owns 502,855 shares in the company, valued at approximately $14,703,480.20. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Keith L. Schilling sold 20,000 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $26.84, for a total value of $536,800.00. Following the transaction, the senior vice president now owns 28,792 shares of the company’s stock, valued at $772,777.28. The disclosure for this sale can be found here. Insiders sold a total of 3,832,103 shares of company stock worth $91,679,369 in the last 90 days. 4.30% of the stock is owned by company insiders.

Hedge Funds Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares during the last quarter. Hood River Capital Management LLC boosted its stake in shares of Aspen Aerogels by 12.2% during the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after buying an additional 357,895 shares during the last quarter. AIGH Capital Management LLC boosted its stake in shares of Aspen Aerogels by 3.0% during the 4th quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock valued at $28,475,000 after buying an additional 52,462 shares during the last quarter. Federated Hermes Inc. lifted its stake in Aspen Aerogels by 53.9% during the fourth quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock worth $18,211,000 after purchasing an additional 404,042 shares during the last quarter. Finally, UniSuper Management Pty Ltd lifted its stake in Aspen Aerogels by 13.5% during the third quarter. UniSuper Management Pty Ltd now owns 1,083,836 shares of the construction company’s stock worth $9,321,000 after purchasing an additional 128,974 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.